INVIVO THERAPEUTICS HOLDING CORP | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Armistice Capital, LLC(4.99%),Steven Boyd(4.99%)
INVIVO THERAPEUTICS HOLDING CORP | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Lind Global Macro Fund, LP(3.9%),Lind Global Partners LLC(3.9%), etc.
InVivo Therapeutics | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-10% Owner Foose Brice
InVivo Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Foose Brice
InVivo Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Brice Foose(0%)
InVivo Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Brice Foose(11.5%)
InVivo Therapeutics | 3: Initial statement of beneficial ownership of securities-10% Owner Foose Brice
InVivo Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Armistice Capital, LLC(9.99%),Steven Boyd(9.99%)
InVivo Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Lind Global Macro Fund, LP(6.3%),Lind Global Partners LLC(6.3%), etc.
InVivo Therapeutics | 4: Statement of changes in beneficial ownership of securities
InVivo Therapeutics | 4: Statement of changes in beneficial ownership of securities
InVivo Therapeutics | 4: Statement of changes in beneficial ownership of securities
InVivo Therapeutics | 4: Statement of changes in beneficial ownership of securities
InVivo Therapeutics | 4: Statement of changes in beneficial ownership of securities
InVivo Therapeutics | 4: Statement of changes in beneficial ownership of securities
InVivo Therapeutics | 4: Statement of changes in beneficial ownership of securities
InVivo Therapeutics | 4: Statement of changes in beneficial ownership of securities
InVivo Therapeutics | D: Filing D
InVivo Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Hamel Heather
InVivo Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Mitchell P. Kopin(2.5%),Daniel B. Asher(2.5%), etc.